Multiomics
Advanced Multiomics Solutions
Develops advanced multiomics labs for genomics research and diagnostics.
We Are A Precision Medicine Enabler
Lifera Omics is a leading provider of genomic and multiomic testing services that empower patients, health systems, biopharma clients, and research institutions.
Lifera Omics represents a pioneering initiative led by Lifera, a biopharmaceutical company wholly owned by the Public Investment Fund, and CENTOGENE, the essential life science partner for data driven answers in rare and neurodegenerative diseases. Leveraging industry leading diagnostics expertise and strong local presence, Lifera Omics is committed to delivering state of the art genetic sequencing tailored to regional needs. Our focus on precision medicine and population health programs aims to enhance the speed and accuracy of clinical diagnoses, bolster local capabilities and capacity, and foster global research collaboration.
This strategic collaboration aligns with the goals of Saudi Vision 2030, as well as broader national priorities driving progress in genomic testing and fostering the growth of the Saudi Arabian biotech sector.
We enable precision medicine through high quality multiomic testing and analysis leveraging a proprietary biodatabank highly enriched for genomic data of the Saudi population.
Our platform leverages proprietary biodata capabilities enriched for the Saudi population to serve diagnostics, population health, research partnerships, and precision medicine programmes with a stronger local context.
Diagnostics
Clinical and Population Health Support
Enhances clinical diagnoses with innovative solutions built for regional healthcare needs.
Precision
Precision Medicine Enablement
Enables precision medicine pathways for rare and common diseases through high quality testing.
Innovation
R&D Partnerships and Expertise
Supports R&D partnerships that strengthen Saudi Arabia's biotech ambitions and clinical research ecosystem.
Delivering life changing answers with genomic and multiomic testing
At Lifera Omics, we understand that a timely and accurate diagnosis is crucial for patients and their families.
>800,000
patients from around the world in the biodatabank
>60,000
Saudi Arabian patients represented in the biodatabank
>70,000,000
unique variants supporting interpretation and discovery